Genfit 9M Total Revenue €36.4 Million
Nov 5 (Reuters) - Genfit SA GNFT.PA:
GENFIT REPORTS THIRD QUARTER 2026 FINANCIAL INFORMATION AND PROVIDES CORPORATE UPDATE
REPORTS CASH AND CASH EQUIVALENTS OF €95.60 MILLION AS OF SEPT 30, 2026; EXPECTED TO FUND THE COMPANY BEYOND 2028
€36.3 MILLION IN REVENUE FOR THE FIRST NINE MONTHS OF 2026 FROM ROYALTIES ON IPSEN’S SALES OF IQIRVO (ELAFIBRANOR), AN INCREASE OF 188% YEAR-OVER-YEAR
9M TOTAL REVENUE €36.4 MILLION
Source text: nGNE8cYs3p
Further company coverage: GNFT.PA